Aripiprazole
Generic Details
Generic Name
Aripiprazole
Other Names
- Abilify
Drug Class
- Atypical Antipsychotic
Chemical Formula
C23H27Cl2N3O2
Molecular Weight
448.38 g/mol
Mechanism of Action
- Partial agonist at dopamine D2 and serotonin 5-HT1A receptors; antagonist at serotonin 5-HT2A receptor
Indications
- Schizophrenia
- Bipolar disorder
- Major depressive disorder
- Autism spectrum disorder
- Tourette's disorder
- Irritability associated with autistic disorder
- Agitation associated with schizophrenia or bipolar disorder
Common Dosage Forms
- Tablet
- Oral solution
Typical Dosage
- 10-15 mg once daily for schizophrenia
- 5-10 mg once daily for bipolar disorder
- 2-5 mg once daily for major depressive disorder
Pediatric Dosage
- Dosage adjustments may be required based on weight and condition
Geriatric Dosage
- Lower starting doses may be needed in the elderly
Side Effects
- Drowsiness
- Headache
- Nervousness
- Insomnia
- Constipation
- Weight gain
- Tremor
Contraindications
- Hypersensitivity to aripiprazole
- Severe cardiac disorders
Pregnancy Category
- C - Risk cannot be ruled out
Lactation Safety
- Limited data available; use with caution
Drug Interactions
- Antidepressants
- Antifungals
- Antipsychotics
- Benzodiazepines
- Beta blockers
Overdose Symptoms
- Extreme drowsiness
- Uncontrolled muscle movements
- Agitation
Antidote for Overdose
- There is no specific antidote; treatment is supportive
Storage Conditions
- Store at room temperature away from moisture and heat
Pharmacokinetics
- Absorption: Well-absorbed orally, peak plasma levels in 3-5 hours
- Distribution: Crosses the blood-brain barrier and placenta, enters breast milk
- Metabolism: Primarily hepatic via CYP2D6 and CYP3A4 enzymes
- Excretion: Mainly via feces (55%) and urine (45%)
Precautions
- Increased risk of suicidal thoughts in children, adolescents, and young adults
- Caution in patients with a history of seizures or neuroleptic malignant syndrome
Warnings
- Increased mortality in elderly patients with dementia-related psychosis